MedTrace Logo

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

NCT02043418 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2025-01-29

No results posted yet for this study

Summary

This study aims to assess the long-term outcomes of children infected with HIV, having participated in the ANRS 12140 PediacamI study, in terms of: clinical and immunovirological response to ARV therapy, long-term ARV tolerance, and the impact of family environment and lifestyle on adherence to ARV treatment.

Conditions

Sponsors & Collaborators

  • Centre Pasteur du Cameroun

    collaborator OTHER

  • Centre Mère et Enfant de la Fondation Chantal Biya

    collaborator OTHER

  • Centre Hospitalier D'essos

    collaborator OTHER

  • Hospital General De Douala

    collaborator OTHER

  • Institut Pasteur

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Mathurin Tejiokem, Dr · Centre Pasteur du Cameroun

  • Albert Faye, Pr · Hopital Universitaire Robert-Debre

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043418 on ClinicalTrials.gov